Oral Microbiol Immunol

Oral Microbiol Immunol selleck chemicals 1998,13(5):322–325.PubMedCrossRef 11. d’Empaire G, Baer MT, Gibson FC: K1 serotype capsular polysaccharide of Porphyromonas gingivalis elicits chemokine production from murine macrophages that facilitates cell migration. Infect Immun 2006,74(11):6236–43.PubMedCrossRef 12. Farquharson

SI, Germaine GR, Gray GR: Isolation and characterization of the cell-surface polysaccharides of Porphyromonas gingivalis ATCC 53978. Oral Microbiol Immunol 2000,15(3):151–157.PubMedCrossRef 13. Davey ME, Duncan MJ: Enhanced biofilm formation and loss of capsule synthesis: deletion of a putative glycosyltransferase in Porphyromonas gingivalis . J Bacteriol 2006,188(15):5510–5523.PubMedCrossRef 14. Rosen G, Sela MN: Coaggregation of Porphyromonas gingivalis and Fusobacterium nucleatum PK 1594 is mediated by capsular polysaccharide and lipopolysaccharide. FEMS Microbiol Lett 2006,256(2):304–310.PubMedCrossRef 15. Domenico P, Salo RJ, Cross AS, Cunha BA: Polysaccharide

capsule-mediated resistance to opsonophagocytosis in Klebsiella pneumoniae . Infect Immun 1994,62(10):4495–4499.PubMed 16. Noel GJ, Hoiseth SK, Edelson PJ: Type b capsule inhibits ingestion of Haemophilus influenzae by murine macrophages: studies with isogenic encapsulated and unencapsulated strains. The Journal of infectious diseases 1992,166(1):178–182.PubMedCrossRef 17. Glynn AA, Howard CJ: The sensitivity to complement of strains of Escherichia coli related to their K antigens. Immunology 1970,18(3):331–346.PubMed 18. Aduse-Opoku J, Slaney JM, Hashim A, Gallagher A, Gallagher RP, Rangarajan M, Boutaga K, Laine ML, van Winkelhoff AJ, Curtis MA: Identification and characterization LCZ696 cost of the capsular polysaccharide (K-antigen) locus of Porphyromonas gingivalis . Infect Immun 2006,74(1):449–460.PubMedCrossRef 19. Chen T, Hosogi Y, Nishikawa K, Abbey K, Fleischmann RD, Walling J, Duncan MJ: Comparative PDGFR inhibitor whole-genome analysis of virulent and avirulent strains of Porphyromonas gingivalis . J Bacteriol 2004,186(16):5473–5479.PubMedCrossRef 20. Scheres N, Laine ML, de Vries

TJ, Everts V, van Winkelhoff AJ: Gingival and periodontal ligament fibroblasts differ in their inflammatory response to viable Porphyromonas gingivalis . J Periodontal Res 2009, in press. 21. Schroeder HE, Munzel-Pedrazzoli S, Page R: Correlated morphometric and biochemical analysis of gingival tissue in early chronic gingivitis in man. Archives of oral biology 1973,18(7):899–923.PubMedCrossRef 22. Lekic PC, Pender N, McCulloch CA: Is fibroblast heterogeneity relevant to the health, diseases, and treatments of periodontal tissues? Crit Rev Oral Biol Med 1997,8(3):253–268.PubMedCrossRef 23. Nagasawa T, Kobayashi H, Kiji M, Aramaki M, Mahanonda R, Kojima T, Murakami Y, Saito M, Morotome Y, Ishikawa I: LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin. Clinical and experimental immunology 2002,130(2):338–344.

Comments are closed.